Skip to main content
OpenTrials
Completed

NCT Number: NCT01488006

Columbia Shoulder Study (CSS)

This prospective study will evaluate the Bigliani/Flatow prosthesis. The aims of this study are to establish the safety, effectiveness, and value of the prosthetic system, and to collect information from expert shoulder surgeons as to features of the implants, instruments, and techniques which may be further improved. In this study, the investigators hypothesize that this prosthetic device will significantly improve long-term patient-based outcomes, functional status and quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Columbia University Medical Center

New York, 10032, United States

About this study

Over the last two decades, total shoulder joint replacement - or arthroplasty - has become a commonly performed procedure for the treatment of painful arthritis of the shoulder, and numerous studies have demonstrated its success. During this time, much has been learned about the efficacy, as well as the complications, of the procedure, and since its introduction in the 1950's, shoulder arthroplasty has undergone an evolution in design. The value of such innovations has not yet been determined and will depend on the results of long term follow-up studies. The purpose of this study is to provide follow-up information and design modification directives.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient must be 18 years of age or over.
  • Patient must have signed The Informed Consent and Release of Medical Information forms.
  • The patient can be a man, postmenopausal woman, or a woman who is likely to become pregnant but is using adequate contraceptive precautions (defined as oral contraceptives, intrauterine devices, surgical contraception or a combination of a condom and spermicide).
  • Patient needs a total shoulder arthroplasty (humeral head and glenoid).
  • Patient has a diagnosis of primary osteoarthritis.

Exclusion criteria

  • Obstacles, which pose an inordinately high surgical risk, in the judgment of the certified surgeon.
  • Class IV or higher anesthetic risk.
  • Patient has a recent history of psychiatric disease (including drug or alcohol abuse) that is likely to impair the compliance with the study protocol.
  • Patient has had a shoulder fracture.
  • Patient had previous shoulder surgeries with the exception of an arthroscopic debridement procedure.
  • The patients has a massive rotator cuff tear (rupture >3 cm or total cicatrisation) demonstrated at time of the surgery that precludes the total shoulder replacement.

Treatment and study plan

Bigliani/Flatow Shoulder System

Device

Primary Total Shoulder Arthroplasty with the Bigliani/Flatow prosthesis

Primary outcomes

  1. Preoperative Radiographic Measurements of Standard Glenohumeral Relationships

    Time frame: Up to 16 weeks prior to date of surgery

  2. Change in Post-operative Radiographic Measurements of Prosthetic Relationships (Anteroposterior and Axillary x-rays)

    Time frame: Up to 5 years postoperatively

    Measurements include acromiohumeral interval, head to tuberosity distance, coracoid to glenohumeral joint distance, coracoid to tuberosity distance, humeral stem position (valgus/varus), humeral congruity and subluxation, glenoid comp version.

  3. Change in Radiographic Analysis for Lucent Lines and Prosthesis Loosening

    Time frame: Up to 5 year postoperatively

    glenoid and humeral component lucency

Secondary outcomes

  1. Change in Score on Short-Form 36 (SF-36)

    Time frame: Up to 5 years postoperatively.

    Mental component score, physical component score, mental health, physical function, role emotional, role physical, social function, vitality, bodily pain and general health

  2. Change in Score on EuroQOL (EQ-5D)

    Time frame: Up to 5 years postoperatively.

    Total index, visual analog scale, mobility, anxiety/depression, pain/discomfort, self-care, and usual activities.

  3. Change in ASES (American Shoulder and Elbow Surgeons) Score

    Time frame: Up to 5 years postoperatively.

  4. Change in Total Score on Simple Shoulder Test (SST)

    Time frame: Up to 5 years postoperatively.

    Total score.

  5. Change in Constant Score

    Time frame: Up to 5 years postoperatively.

  6. Change in Range of Motion

    Time frame: Up to 5 years postoperatively.

    Active and passive external rotation at 90 degrees and at side, active and passive forward elevation, active and passive abduction, active and passive internal rotation

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • Zimmer Biomet

Registry information

Official study title

5- Year Follow-up in Total Shoulder Arthroplasty for Primary Glenohumeral Osteoarthritis: A Prospective Multicenter Study

Acronym: CSS

Important dates

Study start
2001
Primary completion
2009
Study completion
2012
First posted
Dec 8, 2011
Registry last updated
Jul 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.